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ABSTRACT
OBJECTIVE: To describe methodological aspects of the household survey National Survey on 
Access, Use and Promotion of Rational Use of Medicines (PNAUM) related to sampling design 
and implementation, the actual obtained sample, instruments and fieldwork.
METHODS: A cross-sectional, population-based study with probability sampling in three stages 
of the population living in households located in Brazilian urban areas. Fieldwork was carried 
out between September 2013 and February 2014. The data collection instrument included 
questions related to: information about households, residents and respondents; chronic diseases 
and medicines used; use of health services; acute diseases and events treated with drugs; use of 
contraceptives; use of pharmacy services; behaviors that may affect drug use; package inserts 
and packaging; lifestyle and health insurance.
RESULTS: In total, 41,433 interviews were carried out in 20,404 households and 576 urban clusters 
corresponding to 586 census tracts distributed in the five Brazilian regions, according to eight 
domains defined by age and gender.
CONCLUSIONS: The results of the survey may be used as a baseline for future studies aiming 
to assess the impact of government action on drug access and use. For local studies using a 
compatible method, PNAUM may serve as a reference point to evaluate variations in space and 
population. With a comprehensive evaluation of drug-related aspects, PNAUM is a major source 
of data for a variety of analyses to be carried out both at academic and government level.
DESCRIPTORS: Drug Utilization, statistics & numerical data. Pharmaceutical Services, supply 
& distribution. Sampling Studies. Health Surveys, methods. 
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INTRODUCTION
Government investment in health has increased in recent years. Brazilian Ministry of Health 
(MH) expenditure with medicines has accompanied this growth, ranging from R$1.8 billion 
to R$12.4 billion between 2003 and 2014, while maintaining the average budget ratio of about 
14.0%4. Adjusting for inflation over the period, there was a 3.6 times increase in real value. 
Despite increased spending on medicines, no assessment of its impact on drug access and 
use by the Brazilian population was heretofore available.
Strategies to evaluate drug access policies involve various aspects, ranging from 
macroeconomic issues to the obtainment and use of these drugs by the population. 
Evaluation of drug use and access in several countries has been based on models of drug 
supply, which can be via free provision, health insurance coverage, refund or direct paymenta.
National health studies in Brazil date back to 1981, with the first health supplement of the 
Pesquisa Nacional de Amostra por Domicílio (PNAD – National Household Sample Survey), 
repeated in 1986, 1998, 2003 and 2008b,c. The various PNAD editions were limited to surveying 
medicines of long-term use and their forms of access. In the 2013 Pesquisa Nacional de Saúde 
(PNS – National Survey on Health)d, information on obtaining medicines is equivalent to 
that of PNAD, but with separate information for diabetes and high blood pressure14.
The biggest limitation to evaluating drug use in health surveys has been the level of detail. 
Besides the fact that the surveys must address a broad number of topics, measuring drug use 
is complex and involves many difficulties, from recording drug names correctly to questions 
on the various reasons for using medicines and how they are obtained.
Given this situation, the Brazilian Ministry of Health proposed in 2009 the development of 
the first national survey on drug access and use: Pesquisa Nacional Sobre Acesso, Utilização 
e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use 
and Promotion of Rational Use of Medicines). This survey was established by ordinance 
GM/MS 2077 from September 17, 2012 to address the need of information related to drug 
access, use and rational use in Brazil, in accordance with MH strategic objectives, which 
include ensuring pharmaceutical services and reducing inadequate access to health and 
pharmaceutical services provided by the Brazilian Unified Health System (SUS)e.
PNAUM was organized into two components: 1) household survey on drug access, use and 
rational use, the focus of this article, and 2) evaluation of public policies for pharmaceutical 
services and their implementation in SUS Primary Care Health. The PNAUM household 
survey aimed to evaluate the use of medicines by the Brazilian population, characterizing 
the morbidities for which they are used, access indicators and rational use of drugs according 
to demographic, socioeconomic, lifestyle and morbidity variables.
This article aims to describe methodological aspects of the household survey related 
to sampling design and implementation, instruments and fieldwork, as well as the 
sample obtained.
METHODS
PNAUM is a cross-sectional, population-based study with probability sampling, carried 
out between September 2013 and February 2014 in urban households at national level. The 
survey was restricted to the urban population due to logistics difficulties and the additional 
cost involved in studying rural areas.
Sample Design
The medicine use varies according to age and gender regarding the amount and type of 
medication, and it is essential to ensure accurate estimates of both groups. Thus, the sample 
a Brasil, Conselho Nacional de 
Secretários de Saúde. O desafio 
do acesso aos medicamentos 
nos sistemas públicos de 
saúde: relatório do Seminário 
Internacional de Assistência 
Farmacêutica do CONASS. 
2010 [cited 2015 Jan]. Available 
from: http://www.conass.org.br/
conassdocumenta/cd_20.pdf
b Instituto Brasileiro de Geografia 
e Estatística. Pesquisa nacional 
por amostra de domicílios. Rio 
de Janeiro (RJ): IBGE; 2003.
c Instituto Brasileiro de Geografia 
e Estatística. Pesquisa nacional 
por amostra de domicílios. Rio 
de Janeiro (RJ): IBGE; 2008.
d Instituto Brasileiro de Geografia 
e Estatística. Pesquisa Nacional 
de Saúde 2013: percepção do 
estado de saúde, estilos de vida 
e doenças crônicas - Brasil, 
Grandes Regiões e Unidades da 
Federação. Rio de Janeiro (RJ): 
IBGE; 2014.
e Ministério da Saúde. Secretaria 
de Ciência, Tecnologia e Insumos 
Estratégicos, Departamento de 
Ciência e Tecnologia. Pesquisas 
estratégicas para o sistema de 
saúde - PESS. Brasília (DF): 
Ministério da Saúde; 2011.
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included eight demographic domains: (1) ages 0-4, both genders; (2) ages 5-19, both genders; 
(3) ages 20-39, female; (4) ages 20-39, male; (5) ages 40-59, female; (6) ages 40-59, male; 
(7) ages 60 or over, female; (8) ages 60 or over, male.
The demographic domains were replicated for each of the major Brazilian geographical 
regions, resulting in 40 sampling domains, ensuring the accuracy of indicators of 
interest for the subgroups selected within each region. Sample size was defined based 
on estimates obtained from the 2008 PNAD. These estimates were: 34.0% of totally free 
access to medications, 44.0% of paid access and the remainder of mixed access. Also used 
was a 12.0% estimate of lack of access to needed medicines. The precision criterion was 
set at 0.05, the maximum value for variation coefficients from the estimates of interest. 
This resulted in a minimum sample size of 960 interviews per sampling domain, totaling 
38,400 interviews.
The sample was drawn from clusters in three stages: municipality (primary sampling unit), 
census tract and household. The municipalities were selected by systematic sampling 
with probability proportional to size within each region, totaling 60 clusters for each one 
of them. Two tracts within each selected municipality were also selected with probability 
proportional to size. In the third stage, 86, 72, 70, 54 and 61 households were drawn in the 
North, Northeast, Midwest, Southeast and South regions, respectively. This total is the number 
of households increased by 10.0% due to refusal. The household draw used the 2010 Cadastro 
Nacional de Endereços do Censo (National Census Address Register) of the Brazilian Institute 
of Geography and Statistics (IBGE). Before the fieldwork, the tracts were visited for a quick 
household count to detect changes. Tracts with less than 90.0% of update for valid addresses 
were updated immediately prior to the interview and selection process. The household draw 
in each domain was based on the expected percentage for each age and gender group. The 
number of individuals in each group was previously defined in order to compose the sample 
with the desired numbers. In the sample selection process, 2010 Census data were used as 
a source of the number of households and individualsf.
Sampling weights were calculated for individuals, and post-stratification weights were used 
to reduce the bias resulting from low response rate. These weights were calculated by the 
raking method, using the population distribution estimated by the PNS according to age 
and gender per regiong.
The following categories were used to calculate response rates:
1D - actual sample (household with eligible resident);
2D - incompatible profiles (household without eligible resident);
3D - inexistent, not located or inaccessible household;
4D - closed or abandoned household;
5D - refusal (to report about eligible population in household);
6D - non-residential;
7D - not visited (difference between number of addresses predicted and visited).
The response rate for households (TRD) was calculated by:
TRD = 1-
  3D + 4D + 5D + 7D
 1D + 2D + 3D + 4D + 5D + 7D
Non-residential households were excluded from the calculation, as vacant households 
should also have been. The latter were not excluded for lack of information about them. 
Closed households (considered non-responsive) and abandoned households were included 
in a single category.
f Instituto Brasileiro de Geografia 
e Estatística. Censo demográfico 
2010: características da 
população e dos domicílios: 
resultado do universo. Rio de 
Janeiro (RJ): IBGE; 2011.
g Flores-Cervantes I, Brick 
JM; Jones ME. Weighting for 
nontelephone household in 
the 2001 California Health 
Interview Survey. In: Proceedings 
of the Joint Statistical Meetings 
Section on Survey Research 
Methods; 2002 [cited 2016 
Aug 9] Aug 11-15; New York. 
p. 1002-7. Available from: 
http://www.amstat.org/sections/
srms/Proceedings/y2002/Files/
JSM2002-000661.pdf
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For residents, the response rate (TRM) was calculated by:
TRM =
 1M 
 2M
1M - Interviewed resident
2M - Eligible resident
Based on the DHS (Demographic and Health Surveys - Phase IIIh) sampling manual, the 
following was used as overall response rate:
TR = TRD * TRM
In some demographic domains by region, the originally planned sample size was not obtained. 
Thus, a post-stratification process was carried out by applying to the sample observations the 
weights related to the new sampling fractions adjusted by region, gender and age, following 
the Brazilian population distribution from the 2013 PNS. This procedure ensured a sample 
distribution consistent with the distribution of the Brazilian population.
Survey Instruments
A questionnaire for adults was developed with 11 blocks. This questionnaire was adapted to 
be answered by the person responsible for the care of children and incapable people (Table 1). 
Full versions of the questionnaires used are available on the PNAUM website (http://www.
ufrgs.br/pnaum).
Before the actual interview, the name, gender and age of all household residents were 
recorded. This information was used to identify the domains to be interviewed at 
that household.
For “children” (persons below 15 years of age), blocks 2 and 4 were adapted and blocks 5, 7, 8 
and 9 were not used. Blocks 5, 7, 8 and 9 were not used for incapable people either, defined 
here as those unable to communicate or self-report information due to physical or mental 
illness, speech impediment or lack of discernment to answer questions.
The first block features respondent data related to the three groups of people. The second 
investigates chronic diseases and the current use of drugs in each disease. The selection of 
the reasons for drug use was based on the most prevalent health problems in the population 
and the 2008 PNAD Health assessment (IBGE)i. Respondents were asked about the existence 
of medical diagnosis: high blood pressure, diabetes, heart diseases, hypercholesterolemia, 
stroke, lung disease, arthritis, arthrosis or rheumatism, depression and other chronic diseases 
lasting six months or longer. For each medication, detailed information was collected about 
the product (generic, expiry date, dosage form, concentration) and its use (length of time, 
dosage, source, among other information). To identify adherence barriers related to therapy, 
beliefs and memories regarding the long-term use of medications, the Brief Medication 
Questionnaire (BMQ)1 was used.
The third block investigates the types of health services used. Block 4 contains questions 
about the use of drugs in the previous 15 days for acute events or diseases. For each medicine, 
a set of questions was asked to obtain detailed information.
To record data on drugs reported in blocks 2 and 4, respondents were asked to show all 
“medicines” being use. Any product used to cure or alleviate diseases, symptoms, discomfort 
or mild illness was considered medicine. Thus, a medicine could be a compounded or 
processed drug or herbal tea, homeopathic product or medicinal plant, for example.
Block 5 investigates the current use and access to oral and injectable contraceptives, including 
means of obtainment and name of product, as well as data on side effects and treatment 
adherence among women aged 15 to 49. The questions were adapted from the 2006 Pesquisa 
Nacional de Demografia e Saúde (National Demographics and Health Survey)j.
h Macro International Inc. 
Demographic and health survey, 
phase III: sampling manual. 
Maryland: Macro International 
Inc; 1996 [cited 2016 Aug 9]. 
(DHS-III basic documentation, 
n6). Available from: http://
dhsprogram.com/pubs/pdf/
AISM5/DHS_III_Sampling_
Manual.pdf
i Instituto Brasileiro de Geografia 
e Estatística. Pesquisa nacional 
por amostra de domicílios. Rio de 
Janeiro (RJ): IBGE; 2008.
j Ministério da Saúde. Centro 
Brasileiro de Análise e 
Planejamento. Pesquisa Nacional 
de Demografia e Saúde da 
Criança e da Mulher – PNDS 
2006: dimensões do processo 
reprodutivo e da saúde 
da criança. Brasília (DF): 
Ministério da Saúde, 2009 
[cited 2016 Aug 9]. Available 
from: http://bvsms.saude.gov.br/
bvs/publicacoes/pnds_crianca_
mulher.pdf
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Block 6 was designed to identify in detail the sources for obtaining different drugs, given 
that individuals may use various services to obtain all medications needed. Block 7 features 
questions to evaluate behaviors that may affect drug use. Block 8 investigates respondents’ 
habits regarding the reading of the package inserts and drug storage, containing questions 
adapted from Didonet and Mengue (2008) and Silva et al. (2000)12.
Block 9 contains questions related to the use of tobacco and alcohol, based on the 2011 
Vigitelk, and to physical activity based on the Global Physical Activity Questionnaire – GPACl. 
Block 10 asks whether the respondent has health insurance or not and the items covered, 
especially medications.
The last block, consisting of two sections, was used to collect household information. 
The first section gathered information such as household goods, furniture, household 
income and number of rooms in order to apply the Critério de Classificação Econômica Brazil 
k Ministério da Saúde. Secretaria 
de Vigilância em Saúde. 
Secretaria de Gestão Estratégica e 
Participativa. Vigitel Brasil 2010: 
vigilância de fatores de risco e 
proteção para doenças crônicas 
por inquérito telefônico. Brasília 
(DF): Ministério da Saúde; 2011. 
p. 152.
l World Health Organization 
(WHO). Chronic diseases and 
health promotion: global physical 
activity surveillance. Geneva: 
World Health Organization; 2007 
[cited 2016 Aug 9]. Available 
from: http://www.who.int/chp/
steps/GPAQ/en/
Table 1. Breakdown of questionnaires administered to individuals aged > 15, incapable or aged < 14, by blocks. PNAUM, Brazil, 2104.
Block Section
Aged 15 
or over
Incapable of 
answering interview
Aged below 15
1 Respondent information
Gender
Age
Level of education
Marital status
Skin color/ethnicity
Self-reported height and weight
✓
Data of substitute 
respondent: gender, 
age, level of education 
and kinship to 
participant
Data of substitute 
respondent: 
gender, age, level 
of education 
and kinship to 
participant
2 Chronic diseases
High blood pressure
Diabetes
Heart diseases
Hypercholesterolemia
Stroke
Pulmonary disease
Arthritis, arthrosis or rheumatism
Depression
Other chronic diseases lasting 6 months or longer
✓ ✓
Respiratory diseases
Diabetes
Other chronic 
diseases lasting 
6 months or longer
2.1
List of medications for 
chronic diseases
Detailed description of medications used for chronic 
diseases ✓ ✓ ✓
3 Health Services
Use of health services 
Information on medical care ✓ ✓ ✓
4
Acute diseases or events 
treated with medicines
Infection
Sleeping or anxiety problems
Stomach or bowel problems
Flu
Cold or rhinitis
Fever and pain
Use of vitamins, mineral supplements, appetite 
stimulants or tonics
✓ ✓
Nausea, vomiting 
and diarrhea were 
included and 
sleeping or anxiety 
problems were 
excluded
4.1
List of medications for acute 
diseases and events
Detailed description of medications used for acute 
diseases and events ✓ ✓ ✓
5 Contraceptives Oral or injectable contraceptives ✓ ✓ ✓
6 Pharmacy services
SUS pharmacy
Private sector pharmacy 
Popular pharmacy
✓ ✓ ✓
7
Behaviors that may affect 
drug use
People or other sources of reference for indication of 
drugs
Sources of information on drugs
Behaviors related to self-medication and 
non-adherence
Guidance on drug storage
Guidance on drug use length of time
✓
8 Inserts and packaging
Use of inserts
Understanding of inserts ✓
9 Lifestyle
Physical activity
Smoking
Alcohol consumption
✓
10 Health insurance
Health insurance
Insurance coverage ✓ ✓ ✓
11
Household and head of 
household information
Household information
Head of household information ✓ ✓ ✓
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(CCEB – Brazilian Economic Classification Criterion) of Associação Brasileira das Empresas de 
Pesquisa (ABEP – Brazilian Association of Survey Companies). The second section gathered 
sociodemographic information of the head of household.
The interview flowchart according to the order of blocks is described in the Figure.
Fieldwork
Team and Structure
The field team was formed by coordination core, operational support team, and interviewers. 
The coordination core was responsible for overseeing all collection processes and stages. 
The operational support team carried out field supervision and provided logistics and 
administrative support to the teams gathering data. A support center was also set up to 
clarify doubts and solve operational problems, working full time throughout the research.
Two-hundred and seventeen potential interviewers were trained, 165 of whom took part in 
the actual data collection. A three-day training was given by the operational support team 
and PNAUM researchers. The training was organized into six different groups according to 
the Brazilian region where the interviews were done.
Pilot
To test field logistics, six pilot studies were carried out, one in each state capital where the 
training took place, totaling 251 interviews. Items tested at this point included the data 
collection instrument, support manual, data recording software, tablet operation and data 
transmission used in the fieldwork stage.
Survey Disclosure Strategies
Knowledge of the study by the population and institutional support of health and social 
assistance departments could facilitate interviewers’ contact with respondents and increase 
TCLE
Respondent 
information
Chronic diseases List of medications 
for chronic diseases
Pharmacy services
Behaviors that may 
affect drug use
Inserts and packaging
Lifestyle
Health insurance
Information on household 
and head of household
Health services
Acute diseases and 
events treated 
with drugs
List of medications 
for acute diseases 
and events
Is the respondent 
female, aged 15 to 49?
Contraceptives
End of visit 
Does the 
respondent 
have any 
chronic diseases?
Did he/she report 
the use of any
 medicine to treat 
this(these) chronic 
event(s)?
Did he/she report
 the use of any 
medicine to 
treat this(these) 
chronic disease(es)?
Yes
Yes
Yes
No
No
Yes
No
No
TCLE: Informed consent
Figure. Interview flowchart. The upper flowchart refers to interviews with adults and the bottom to interviews with incapable people and 
children. PNAUM, Brazil, 2014.
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participation. Thus, brochures, posters and letters explaining the survey were distributed 
at the locations drawn for data collection, and the Health Hotline (136) was used for the 
population to confirm the veracity of the survey.
Data Collection
Having the required number of households per census tract was essential for the household 
draw. Thus, 124 census tracts required previous inventory due to the lack of updated 
information on the total number of households.
In households with eligible age groups, the interviewer would identify all residents through 
the person available at the first contact and carry out the interview with individuals from 
the selected age group. The household questions were answered by the head of household, 
while those related to the other blocks were answered individually by the respondents. 
In the case of children under 15 and incapable persons, the interview was conducted with 
the person named as responsible for their medication.
Quality Control
The quality control of the interviews was carried out through re-interviews with part of the 
sample, regular analysis during the survey of the frequency of investigated variables, and 
analysis of database consistency.
The re-interviews were conducted through telephone calls, using a standardized questionnaire 
with drawn respondents. This stage involved 5.123 re-interviews, corresponding to 12.0% of 
the sample. The reproducibility of variables was tested from the answers, and Kappa values 
were obtained showing a high level of agreement, ranging from 0.723 to 0.879.
Moreover, variable frequencies were monitored throughout the whole fieldwork, related to 
sociodemographic data, self-reported diseases, health service use, drug use, lifestyle, health 
insurance and assets. The values  obtained were routinely compared with the most recent 
results of national surveys.
Ethical Aspects
PNAUM was approved by Comissão Nacional de Ética em Pesquisa (National Research 
Ethics Commission – Protocol 18947013.6.0000.0008) and Comitê de Ética em Pesquisa 
da Universidade Federal do Rio Grande do Sul (Research Ethics Committee of the Federal 
University of Rio Grande do Sul – Protocol 19997).  All interviews were conducted after the 
respondents or their legal representatives (in the case of incapable persons) had read and 
signed the informed consent, with assurance of confidentiality and anonymity.
RESULTS
Response Rates
Response rates for households were between 42.0% and 60.0%, including as losses those 
households that, despite featuring in the draw list, were not visited because their residents 
could not be contacted. Among those are temporarily or permanently vacant households, 
since the survey kept no specific record for non-visited households. Response rates for 
individuals were between 82.0% and 97.0%. Overall response rates ranged from 46.6% to 
56.1%. Due to the inclusion of vacant homes among losses, response rate values are somewhat 
underestimated. Table 2 features response rates by demographic domains and region.
A negative correlation was clear between average income of the tract and overall response 
rate, albeit low, ranging from -0.39 to -0.02 (Table 3). Statistically significant correlations 
were observed between the different regions, age groups and genders, especially between 
adults and older adults.
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Sample Description
The survey interviewed 41,433 people who, following adjustments by region, gender and 
age, represent approximately 171 million Brazilians living in urban areas of the country. 
The interviews were conducted in 20,404 households and 576 clusters corresponding to 
586 census tracts (10 census tracts were joined to others due to their small size). The numbers 
of interviews by region and demographic domain are featured in Table 4.
Table 5 features the general characteristics of the sampled population, according to age 
group, gender, self-reported skin color, level of education, marital status, economic class 
and geographical region. The Southeast region represented 45.9% of the sample; Northeast, 
24.3%; South, 14.3%; Midwest, 7.9%; and North, 7.5%. There was a slight predominance 
of females (52.8%); 31.9% were aged 20-39; and 46.0% self-reported as white. Blacks and 
mulattoes combined are the majority among the population (52.5%). Economic bracket 
C was predominant, accounting for 55.3% of respondents. Of individuals aged 20 or older, 
36.1% reported zero to three years of study.
Table 2. Households not visited and response rates, by region and age and gender domain. PNAUM, 
Brazil, 2014.
Region/Age and gender domain
% households 
not visited
Response  
rate/household
Response 
rate/
individual
Overall 
response rate
Region
North 12.4 58.8 95.3 56.1
Northeast 17.5 53.6 95.3 50.1
Southeast 10.1 58.1 91.2 53.0
South 17.6 53.5 93.1 49.8
Midwest 34.4 42.4 91.5 38.8
Domain:  
(age group, gender)
0 to 4 18.1 52.8 95.2 50.2
5 to 19 16.6 60.5 82.8 50.1
20 to 39, male 16.7 58.8 84.0 49.3
20 to 39, 
female
19.6 55.1 96.9 53.4
40 to 59, male 19.1 55.1 93.6 51.6
40 to 59, 
female
18.9 54.1 96.7 52.3
≥ 60, male 18.1 51.7 90.1 46.6
≥ 60, female 18.1 51.5 93.7 48.3
Table 3. Correlation between average income of tract and overall response rate per domain according 
to region. PNAUM, Brazil, 2014.
Domain  
(age group, gender)
Measurements
Region
North Northeast Southeast South Midwest
0 to 4 
Correlation -0.14 -0.21 -0.17 -0.23 -0.29
p 0.13 0.03 0.09 0.02 < 0.01
5 to 19 
Correlation -0.02 -0.10 -0.06 −0.24 -0.33
p 0.86 0.31 0.58 0.02 < 0.01
20 to 39, male
Correlation -0.10 -0.09 -0.23 -0.28 -0.16
p 0.31 0.40 0.02 0.01 0.17
20 to 39, female
Correlation -0.21 -0.28 -0.20 -0.36 -0.29
p 0.02 < 0.01 0.04 < 0.01 < 0.01
40 to 59, male
Correlation -0.14 -0.28 -0.18 -0.31 -0.26
p 0.13 < 0.01 0.05 < 0.01 0.01
40 to 59, female
Correlation -0.21 -0.32 -0.30 -0.24 -0.22
p 0.02 < 0.01 < 0.01 0.01 0.03
60 or over, male
Correlation -0.19 -0.32 -0.19 -0.22 -0.35
p 0.04 < 0.01 0.05 0.02 < 0.01
60 or over, female
Correlation -0.18 -0.32 -0.25 -0.39 -0.34
p 0.05 < 0.01 0.01 < 0.01 < 0.01
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DISCUSSION
PNAUM is the first population-based survey on drug access and use carried out in Brazil 
with national representation. Previous studies in the area were conducted using different 
methods, diverse target populations and local scope, which hindered comparison of results 
and limited the generalization of findings to the Brazilian population. The information 
obtained in this study enables the assessment of drug use profiles and the impact of Brazilian 
drug policies on access to medicines.
Table 4. Number of interviews made by region and demographic domain. PNAUM, Brazil, 2014.
Region
Domain*
TotalAge (years) and gender
0-4 5-19 20-39 20-39 40-59 40-59 ≥ 60 ≥ 60
MF MF M F M F M F
North 1.835 667 552 2.538 1.539 1.778 899 1.115 10.923
Northeast 1.267 618 454 1.881 991 1.521 794 1.268 8.794
Southeast 817 606 533 1.363 1.059 1.267 728 1.125 7.498
South 872 877 562 1.365 1.078 1.299 784 1.009 7.846
Midwest 989 537 336 1.281 839 1.093 554 743 6.372
Total 5.780 3.305 2.437 8.428 5.506 6.958 3.759 5.260
* The domains refer to the age and gender groups (M = male; F = female; MF = male and female).
Table 5. Sample breakdown by demographic and socioeconomic characteristics. PNAUM, Brazil, 
2014. (N = 41,433)
Variable Category %a 95%CI
Age group (years) 
0-4 6.2 5.9–6.5
5-10 9.1 8.3–9.8
11-19 14.4 13.3–15.5
20-39 31.9 30.4–33.3
40-59 25.3 24.3–26.4
≥ 60 13.2 12.4–14.0
Gender
Male 47.2 46.3–48.1
Female 52.8 51.9–53.7
Skin color or ethnicity (self-
reported)
White 46.0 43.5–48.6
Black 8.7 7.9–9.7
Mulatto 43.8 41.5–46.1
Yellow 1.1 0.9–1.3
Indigenous 0.4 0.3–0.5
Level of educationb
0-3 years 36.1 34.5–37.7
4-11 years 31.9 30.8–33.0
≥ 12 years 32.0 30.6–33.5
Marital statusb
Partner 60.7 59.4–62.1
No partner 39.3 37.9–40.6
CCEBc
A 0.5 0.3–0.9
B 21.9 20.0–23.9
C 55.3 53.7–57.0
D 17.7 16.1–19.5
E 4.6 4.0–5.3
Region
North 7.5 5.9–9.5
Northeast 24.3 20.1–29.1
Southeast 45.9 40.0–52.0
South 14.3 11.5–17.8
Midwest 7.9 6.2–10.0
a Percentage adjusted for sampling weights and post-stratification according to age and gender. 
b Only adults aged 20 or over.
c Classified according to Critério de Classificação Econômica Brasil 2013 (CCEB 2013 – Brazilian Economic 
Classification Criterion) of Associação Brasileira de Empresas de Pesquisa (ABEP – Brazilian Association of Survey 
Companies). Available from: http://www.abep.org 
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Studies on drug use can be divided into two groups. The first performs secondary analyses 
of databases of direct or refunded payments for medicines. In such cases, the analyses do 
not address the actual use of drugs nor those acquired outside the health system. These 
are the most used studies in developed countries with integrated information systems. The 
second group performs household surveys, face-to-face or by phone. These are primarily 
used in countries that do not have such information systems – generally poorer countries.
In general, the surveys have a restricted approach to individual drug use, either limited to a 
group of diseases, with questions such as “use or not,” or providing a list of medicines from 
which the user is asked to give information11. Others, such as the Australian Health Study, 
ask for a list of medicines and investigate use for specific diseasesm.
More detailed, nationwide studies have been conducted in the United States and include the 
Slone Survey (2004 to 2006) and the Medical Expenditure Panel Survey (MEPS) that, since 
1996, collects data on prescription and over-the-counter drugsn.
In countries of Africa, Asia, Latin America and the Caribbean, studies on drug access and use 
have been performed using the methodology proposed by the World Health Organization 
and also adopted by the Medicines Transparency Alliance (MeTA)8. The model addresses a 
comprehensive assessment of drug policy in countries, ranging from government aspects 
through public and private services to household surveys3.
Some of the methodological challenges and constraints identified in this study are 
discussed below.
Comparisons with other national household studies show that response rates are lower 
than those obtained by the IBGE in the 2013 PNS, in which the response rate was 91.9% for 
households and 86.0% for individuals, resulting in an overall response rate of 79.0%. However, 
such comparisons are compromised, since the PNS estimate excluded vacant households. 
PNAUM, on the contrary, preserved vacant households in the calculation due to the lack of 
field records. The Pesquisa Nacional de Saúde Bucalo (National Oral Health Survey) obtained 
general response rates ranging from 27.6% in Cuiabá (MT) to 134.3% in Porto Alegre (RS). 
The study did not describe the overall response rate, but a rough estimate shows that, for 
people aged 35 to 44, the average overall response rate is 50.0%. For older adults and children, 
this value was above 80.0%, ranging from 55.0% to 100%.
Response rates in household surveys have shown a steady decline in the last 40 years almost 
all over the world. In the United States, the National Health Survey Interview showed a 
decrease in response rate from 92.0% in 1997 to 89.0% in 2004; the National Expenditure 
Panel Survey, from 78.0% in 1996 to 53.0% in 2014; and the Behavioral Risk Factor Surveillance 
System, from 71.4% in 1993 to 48.9% in 2000 and 51.1% in 20057. Tolonen et al. observed a 
reduction in response rate in the Finnish Adult Health Behaviour Survey response rate from 
80.0% in 1978 to 60.0% in 2002. In an evaluation of the results of surveys conducted in Europe 
between 2007 and 2012, Mindell et al.10 considered as good the response rates of 66.0% in 
England, 54.0% in Germany and 45.0% in the Netherlands.
In previous studies that discuss the reduction of response rates, a few reasons are most 
frequently suggested. The first is people’s reaction to a great number of surveys carried 
out in the most diverse areas, such as market, politics and health. Telephone surveys 
have particularly bothered people, since they are linked to marketing activities in general. 
A growing concern with privacy has influenced the decline in response rates. In PNAUM, 
part of the population worried greatly about safety, which significantly prevented access 
to residents of larger buildings. This kind of worry seems to be an additional component 
diminishing the receptivity of people to household surveys.
The quality of information obtained through interviews is a problem to be considered. 
Of used medicines, 39.0% had no packaging available. In such cases, drug identification is 
based solely on report, which requires comprehensive reviews and subsequent correction to 
m National Health Survey: Users’ 
Guide – Eletronic. Canberra: 
Australian Bureau of Statistics; 
2009 [cited 2016 Aug 9]. 
Available from: http://www.
ausstats.abs.gov.au/ausstats/
subscriber.nsf/0/CC0FB5A0857
0984ECA25762E0017CF2B/$Fi
le/4363055001_2007-08.pdf
n Slone. Epidemiology Center. 
Slone SurveyTM. Boston: 
Boston University; 2006 
[cited 2016 Aug 9]. Available 
from: http://www.bu.edu/slone/
research/studies/slone-survey/ 
o Ministério da Saúde. Secretaria 
de Atenção à Saúde. Secretaria 
de Vigilância em Saúde. 
SB Brasil 2010: Pesquisa 
Nacional de Saúde Bucal: 
resultados principais. Brasília 
(DF): Ministério da Saúde, 2012 
[cited 2016 Aug 9]. Available 
from: http://bvsms.saude.gov.
br/bvs/publicacoes/pesquisa_
nacional_saude_bucal.pdf
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data collection. Approximately 4.0% of all medicines used could not be identified. In addition 
to those, food supplements, or food reported as medicine, medicinal plants and cosmetics 
amounted to 4.1%. In some cases, even with the packaging in hand, respondents were not able 
to link the drugs to each one of the treated diseases. This generated inconsistent information 
between the declared disease and the therapeutic indication of the drug.
The correct identification of medicines is a common difficulty in household studies. 
Contraceptives or vitamins, e.g., are frequently omitted in spontaneous reports on 
medicines when they are not being used to treat any disease. On the other hand, food 
supplements and other products are often reported as drugs to treat diseases. It should 
be noted that some medications have what might be called a “compound name,” with the 
first word identifying the product and the second referring to a different composition, 
which results in another pharmaceutical product. At the same time, medicines may 
come in different concentrations, which may relate to different uses (such as case of 
acetylsalicylic acid 345 mg and 500 mg). Additionally, some fixed–dose combinations 
have different proportions in each dosage form. This demands hard work to identify and 
classify products following data collection to generate the necessary knowledge on the 
use of those therapeutic resources.
Moreover, respondents’ perception of the definition of chronic disease demands analysis to 
produce a classification that enables the best possible expression of the health conditions 
described by people9.
Correct identification of where the respondents obtained their medicines was a limitation 
in data collection. There are several ways of obtaining discount drugs, such as customer 
loyalty programs, which coexist, for example, with the program Aqui tem Farmácia Popular 
(Popular Pharmacy Here). At the same time, supply of medicines financed by SUS can occur 
in health facilities or public health pharmacies with mixed systems, in which part of the 
drugs is available in health facilities and part in centralized pharmacies.
The assessment of acute events examined the use of drugs to treat such diseases or their 
symptoms. Prevalence of these events, treated with non-pharmacological approaches or 
untreated, was not estimated.
The PNAUM instruments were developed in paper form. The blocks were first tested 
separately, with the complete tool assembled for final testing in a second stage. The electronic 
device version was developed later and reviewed during the pilot study. Transference of 
questionnaires to the small-screen tablet system revealed difficulties not observed in the 
hard copy versions and facilities available only to electronic equipment. This showed that, 
at least for this type of survey, electronic versions for testing should be used as soon as 
possible in the development of data collection instruments.
The use of these portable electronic devices in data collection also adds more stages to 
interviewer training. The first stage deals with the use of the actual equipment. The second 
covers the specifics of the software used in developing the application. The third stage is 
when the actual content training begins.
PNAUM fieldwork was carried out by a survey company hired specifically for this 
investigation. Working with contractors requires special care, especially regarding the 
schedule of each stage, proper sizing of field teams, monitoring progress and interviewing 
goals in each sample domain.
PNAUM is the first large national survey to face the challenge of investigating drugs in detail. 
Objective assessment of drug use requires identifying exactly which drugs are being used, 
which drugs are missing and why, where each product is obtained and how each product is 
being used. This information is needed to guide public programs, whether aimed at specific 
diseases or general coverage. In short, knowing what is being used, by whom, where and 
why is what guides the development of this initiative.
12s
Methodological aspects of PNAUM-ID Mengue SS et al.
DOI:10.1590/S1518-8787.2016050006156
PNAUM may be used as a baseline for future studies aiming to assess the impact of 
government action on drug access and use. For local studies using a compatible method, 
PNAUM may serve as a reference point to evaluate variations in space and population. With 
a comprehensive evaluation of drug-related aspects, PNAUM is a major source of data for a 
variety of analyses to be carried out at both academic and government level.
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